![MoleculaImgLarge](https://www.zandallc.com/wp-content/uploads/2022/12/MoleculaImgLarge.png)
Our model is to supply innovative ingredients to leading dietary supplement brands with unique marketing claims.
![image43](https://www.zandallc.com/wp-content/uploads/2021/03/image43.jpg)
GoalDelight dietary supplement brands by delivering innovative nutra technology advancements that become essential to the way we live
![image44](https://www.zandallc.com/wp-content/uploads/2021/03/image44.jpg)
These advancements are done though clinical trialsOver 95 human clinical trials have been conducted in the development of Zanda’s technologies offerings
![icon3](https://www.zandallc.com/wp-content/uploads/2021/03/icon3.png)
Over 95 human trials in product development
![](https://www.zandallc.com/wp-content/uploads/2022/12/icon_grahp9.png)
The combined portfolio R&D expenditure is well over $40 million
![](https://www.zandallc.com/wp-content/uploads/2022/12/world_icon.png)
Our technologies are being sold in over 20 countries
![](https://www.zandallc.com/wp-content/uploads/2022/12/40_113663.png)